Pliant Therapeutics (NASDAQ:PLRX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Pliant Therapeutics (PLRX) operate in?

Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Pliant Therapeutics Stock (NASDAQ: PLRX) stock price, news, charts, stock research, profile.

Open	$11.15
Close	$10.92
Volume / Avg.	434.46K / 513.39K
Day Range	$10.81 - $11.29
52 Wk Range	10.22 - 18.92
Market Cap	$664.52M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	36
Short Interest	12.03%
Days to Cover	10.34

Recent News

Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Pliant Therapeutics' Drug Trial Shows Promise In Reversing Lung Fibrosis In Patients

Phase 2a trial results of Pliant Therapeutics' bexotegrast (PLN-74809) for idiopathic pulmonary fibrosis. Reduced lung collagen, improved FVC, and cough severity, signaling potential fibrosis reversal.

Vandana Singh

These Analysts Revise Their Forecasts On Pliant Therapeutics Following Q1 Earnings

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Sep 24

Nov 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$11.15
Close	$10.92
Volume / Avg.	434.46K / 513.39K
Day Range	$10.81 - $11.29
52 Wk Range	10.22 - 18.92
Market Cap	$664.52M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	36
Short Interest	12.03%
Days to Cover	10.34

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Pliant Therapeutics (PLRX) stock?

You can purchase shares of Pliant Therapeutics (NASDAQ:PLRX) through any online brokerage.

View our list of the best stock brokerages

Who are Pliant Therapeutics (PLRX) competitors?

Other companies in Pliant Therapeutics’s space includes: Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and Xeris Biopharma Holdings (NASDAQ:XERS).

What is the forecast, or price target, for Pliant Therapeutics (PLRX) stock?

Pliant Therapeutics has a consensus price target of $40.62.

What is the current price for Pliant Therapeutics (PLRX)?

The stock price for Pliant Therapeutics (NASDAQ: PLRX) is $10.92 last updated January 24, 2025 at 4:00 PM EST.

Does Pliant Therapeutics (PLRX) pay a dividend?

There are no upcoming dividends for Pliant Therapeutics.

When is Pliant Therapeutics (NASDAQ:PLRX) reporting earnings?

Pliant Therapeutics’s Q4 earnings are confirmed for Wednesday, February 26, 2025.

Is Pliant Therapeutics (PLRX) going to split?

There is no upcoming split for Pliant Therapeutics.

What sector and industry does Pliant Therapeutics (PLRX) operate in?

Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Pliant Therapeutics

Pliant Therapeutics (PLRX) Forecast